5.0
Mar 6, 2026
Current employee, more than 3 years
Washington, DC
Recommend
CEO approval
Business Outlook
Pros
Product is impactful to patients and winning in market; innovative culture and team. Big logos/customers. Strong R&D culture.
Cons
Long hours and lots of travel. Low pay compared to larger AI firms. DC location 2nd tier for pharma tech. Invest in Finance/Ops.